Debt-to-equity of Alzamend Neuro, Inc. from 31 Jan 2023 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Alzamend Neuro, Inc. quarterly Debt-to-equity in % history and change rate from 31 Jan 2023 to 31 Oct 2025.
  • Alzamend Neuro, Inc. Debt-to-equity for the quarter ending 31 Oct 2025 was 18%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 18% +294% 31 Oct 2025
Q2 2025 22% +155% 31 Jul 2025
Q1 2025 55% +202% 30 Apr 2025
Q4 2024 238% +583% 31 Jan 2025
Q3 2024 -276% -471% -242% 31 Oct 2024
Q2 2024 -133% -190% -337% 31 Jul 2024
Q1 2024 -147% -175% -619% 30 Apr 2024
Q4 2023 -345% -361% -2188% 31 Jan 2024
Q3 2023 195% 31 Oct 2023
Q2 2023 56% 31 Jul 2023
Q1 2023 28% 30 Apr 2023
Q4 2022 17% 31 Jan 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.